Introduction: The Bonebridge is an active transcutaneous semi-implantable bone conduction hearing device suitable for several types of hearing loss. It has unique benefits over some more established technologies. It consists of internal active implant and an external sound processor. It was first launched in 2012, with a newer model released in late 2019.
Areas Covered: The structure and features of the device are described. Indications, audiological criteria and contraindications to implantation are discussed. The planning and procedure of implantation surgery is also described. Research outlining the outcomes of implant use and risk of adverse events is highlighted.
Expert Opinion: The evidence included in this article demonstrates the successful audiological outcomes and patient satisfaction with Bonebridge implantation. The rate of adverse events following surgery is low and compares well with other devices which may be considered for Bonebridge candidates. The device should be considered as an option for suitable candidates and in many cases may be the better option available, given the low incidence of skin complications and the absence of a skin penetrating abutment. Future advances are likely to affect sound processor technology, connectivity and possibly further reduction in implant size and gain.
- Bone Conduction
- Hearing Aids
- Hearing Loss
- Prostheses and Implants